Rhythm Pharm Flashcards

1
Q

Rate and Rhythm Control

A
Beta blockers
CCB
Amiodarone
Adenosine
Atropine
Dofetilide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Beta blockers + CCN: Goal

A

HR < 100 BPM + Regular Sinus Rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amiodarone: MOA

A

Prolongs the AP duration and the effective refractory period in ALL cardiac tissues
Blocks Alpha + Beta adrenergic receptors in the SNS
-Helps convert rhythms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amiodarone: Route

A

IV or PO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Amiodarone: Indication

A

One of the most effective antidysrhythmic for PSVT and ventricular dysrhythmias also used for AFIB and RVR

PSVT: Paroxysmal supraventricular tachycardia: Fast rhythm that happens from “time to time” that originates above the ventricles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Amiodarone: AE

A
LOTS
75% have AE 
-Thyroid alterations (contains iodine)
-Corneal microdeposits (fat)
-Pulmonary toxicity (fatal in 10%)
-Black BOX: PULMONARY TOXICITY , hepatotoxicity, and pro-arrhythmic effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Amiodarone: Interactions

A

Digitoxin + Warfarin

  • increases digitoxin levels by 50%
  • Increases INR by 50-100%
  • Warfarin + amiodarone = Bleeding!

EXTREMELY long half-life (many days!)
-if someone has adverse effects, may take 2-3 months for them to fully go away

CONTRAINDICATED w/severe bradycardia or heartblocks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Amiodarone: Contraindications

A
  • Severe Bradycardia

- Heart blocks (type of rhythm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment for Sinus Brady

A

Atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Atropine: Class

A

Anticholinergic/Antimuscarinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Atropine: MOA

A

Poisons vagal nerve
-inhibits postganglionic acetylcholine receptors and direct vagolytic action
(stimulant action)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Atropine: Route

A

IV push ONLY for bradycardia

  • 1 mg every 3-5 mins, 3 mg MAX
  • Only works for 28% of bradycardia cases
  • Must be vagal induced bradycardia!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Atropine: SE

A
(Anticholinergic effects)
Xerostomia
blurry vision
photophobia
Tachycardia
Flushing 
Hot skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atropine: Nursing Implications

A

Need to be on cardiac monitoring, if doesn’t work quickly, give a SECOND dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of PSVT

A

Adenosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adenosine: MOA

A

Slows conduction time through the AV node

VERY SHORT HALF-LIFE
-may need multiple doses

Commonly causes a short burst of asystole until sinus rhythm returns

17
Q

Adenosine: SE

A

Other than Burst of Asystole (flatline), Very few

18
Q

Adenosine: Route

A

ONLY IV

19
Q

Adenosine: Administration

A

6mg IVP, if not converted give 12mg IVP, can give 3rd time 12mg IVP

  • always follow with rapid normal saline flush or 2 saline flushes
  • Uses syringe and 3-way stopcock
20
Q

Dofetilide (Tikosyn): Class

A

Antidysrhythmic

21
Q

Dofetilide (Tikosyn): Indications

A

Conversion from AFIB/aflutter to NSR (Normal sinus rhythm)

22
Q

Dofetilide (Tikosyn): MOA

A

Selectively blocking the rapid cardiac ion channel carrying potassium currents

23
Q

Dofetilide (Tikosyn): SE

A
TORSADE's
SVT
Headache
Dizziness
Chest pain
24
Q

Dofetilide (Tikosyn): Nursing implications

A

Started in-hospital with ECG monitoring due to risk of Torsade’s (Black Box Warning)
-Don’t give to patients with long QT intervals or with other drugs that may prolong QT intervals

25
Q

Torsade’s

A

A type of VTACH

-Deadly Rhythm, start CPR!

26
Q

Warfarin Stuff

A

Put in here